Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Survey: Supportive oncodermatology program improves QOL for cancer patients

Publish date:: April 28, 2020

Key clinical point: Participation in a supportive program may improve quality of life in cancer patients with dermatologic effects from treatment.

Major finding: Average quality of life scores declined from significantly from 6.5 to 3.8 among participants.

Study details: A survey of 34 participants in a supportive oncodermatology clinic.

Disclosures: This study was funded by a La Roche–Posay grant. Ms. Aizman reported having no disclosures. One coauthor reported relationships involving consulting and/or honoraria with several companies, including La Roche–Posay.

Citation:

Aizman L et al. J Drugs Dermatol. 2020 Apr 17. doi: 10.36849/JDD.2020.5040.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

More severe AD correlates with worse sleep health and attention problems in children,

Shortcomings identified in study of acne videos on TikTok,

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Must Reads in Medical Dermatology

New lupus classification criteria perform well in children, young adults,

Phone outreach intervention feasible to reduce SLE readmissions,

Age, smoking among leading cancer risk factors for SLE patients,

Cachexia affects more than half of lupus patients,

Ixekizumab deemed effective for pityriasis rubra pilaris,